Cited by

• Learning about COVID-19 across borders: public health information and adherence among international travellers to the UK.

  Cai S, Zhang T, Robin C, Sawyer C, Rice W, Smith LE, Amlôt R, Rubin GJ, Yardley L, Hickman M, Oliver I, Lambert H. Cai S, et al. Public Health. 2022 Feb;203:9-14. doi: 10.1016/j.puhe.2021.11.015. Epub 2021 Nov 27. Public Health. 2022. PMID: 34999485 Free PMC article.
• COVID-19 morbidity in Afghanistan: a nationwide, population-based seroepidemiological study.

  Saeedzai SA, Sahak MN, Arifi F, Abdelkreem Aly E, Gurp MV, White LJ, Chen S, Barakat A, Azim G, Rasoly B, Safi S, Flegg JA, Ahmed N, Ahadi MJ, Achakzai NM, AbouZeid A. Saeedzai SA, et al. BMJ Open. 2022 Jul 27;12(7):e060739. doi: 10.1136/bmjopen-2021-060739. BMJ Open. 2022. PMID: 35896297 Free PMC article.
• Delta variant and black fungal invasion: A bidirectional assault might worsen the massive second/third stream of COVID-19 outbreak in South-Asia.

  Bari MS, Hossain MJ, Akhter S, Emran TB. Bari MS, et al. Ethics Med Public Health. 2021 Dec;19:100722. doi: 10.1016/j.jemep.2021.100722. Epub 2021 Sep 4. Ethics Med Public Health. 2021. PMID: 34514076 Free PMC article.
• Intranasal Vaccination Strategy to Control the COVID-19 Pandemic from a Veterinary Medicine Perspective.

  Annas S, Zamri-Saad M. Annas S, et al. Animals (Basel). 2021 Jun 24;11(7):1876. doi: 10.3390/ani11071876. Animals (Basel). 2021. PMID: 34202429 Free PMC article.
• Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccination.

  Davis C, Logan N, Tyson G, Orton R, Harvey WT, Perkins JS, Mollett G, Blacow RM; COVID-19 Genomics UK (COG-UK) Consortium; Peacock TP, Barclay WS, Cherepanov P, Palmarini M, Murcia PR, Patel AH, Robertson DL, Haughney J, Thomson EC, Willett BJ; COVID-19 DeplOyed VaccinE (DOVE) Cohort Study investigators. Davis C, et al. PLoS Pathog. 2021 Dec 2;17(12):e1010022. doi: 10.1371/journal.ppat.1010022. eCollection 2021 Dec. PLoS Pathog. 2021. PMID: 34855916 Free PMC article.